{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17112421", "DateCompleted": {"Year": "2007", "Month": "11", "Day": "06"}, "DateRevised": {"Year": "2014", "Month": "11", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1671-4083", "JournalIssue": {"Volume": "27", "Issue": "12", "PubDate": {"Year": "2006", "Month": "Dec"}}, "Title": "Acta pharmacologica Sinica", "ISOAbbreviation": "Acta Pharmacol Sin"}, "ArticleTitle": "Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.", "Pagination": {"StartPage": "1642", "EndPage": "1646", "MedlinePgn": "1642-6"}, "Abstract": {"AbstractText": ["To study the intravenous and oral pharmacokinetic behavior of oridonin and its extent of absolute oral bioavailability in rats.", "Oridonin was administered to rats via iv (5, 10 and 15 mg/kg), po (20, 40 and 80 mg/kg) or ip administration (10 mg/kg). The concentrations of oridonin in rat plasma were determined by a high performance liquid chromatography with electrospray ionization mass spectrometric detection (HPLC/ESI-MS) method and the pharmacokinetic parameters were determined by non-compartmental analysis.", "The plasma concentration of oridonin after intravenous administration decreased polyexponentially, and the pharmacokinetic parameters of oridonin were dose-independent within the examined range. Oridonin was absorbed rapidly after oral gavage with a t(max) of less than 15 min; the extent of absolute bioavailability of oridonin following oral administration was 4.32%, 4.58% and 10.8%. The extent of absolute bioavailability of oridonin following intraperitoneal administration was 12.6%.", "First order rate pharmacokinetics were observed for oridonin within the range of iv doses, while the extent of absolute oral bioavailability was rather low and dose- dependent. The low and dose-dependent extent of oral bioavailability may be due to the saturation of first-pass effects."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China."}], "Identifier": [], "LastName": "Xu", "ForeName": "Wen", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sun", "ForeName": "Jin", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Ting-ting", "Initials": "TT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ma", "ForeName": "Bo", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cui", "ForeName": "Sheng-miao", "Initials": "SM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chen", "ForeName": "Da-wei", "Initials": "DW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "He", "ForeName": "Zhong-gui", "Initials": "ZG"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Acta Pharmacol Sin", "NlmUniqueID": "100956087", "ISSNLinking": "1671-4083"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Diterpenes, Kaurane"}, {"RegistryNumber": "0APJ98UCLQ", "NameOfSubstance": "oridonin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Area Under Curve"}, {"QualifierName": [], "DescriptorName": "Biological Availability"}, {"QualifierName": ["administration & dosage", "isolation & purification", "pharmacokinetics"], "DescriptorName": "Diterpenes"}, {"QualifierName": ["administration & dosage", "isolation & purification", "pharmacokinetics"], "DescriptorName": "Diterpenes, Kaurane"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Injections, Intraperitoneal"}, {"QualifierName": [], "DescriptorName": "Injections, Intravenous"}, {"QualifierName": ["chemistry"], "DescriptorName": "Isodon"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2006", "Month": "11", "Day": "23", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "11", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "11", "Day": "23", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17112421", "10.1111/j.1745-7254.2006.00440.x"]}}], "PubmedBookArticle": []}